The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Imdelltra Amgen Australia Pty Ltd
Product name
Imdelltra
Sponsor
Accepted date
Jul-2024
Active ingredients
tarlatamab
Proposed indication
Treatment of adult patients with advanced small cell lung cancer.
Application type
A (new medicine)
Publication date
Jul-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.
Provisional registration
Involves early access to vital and life-saving medicines through time-limited registration.